skip to content
Primary navigation


DrugAzilect (rasagline) 0.5 mg, 1mg

November 2007

Therapeutic area - Parkinson’s disease

Azilect (rasagline)

Azilect is an MOA inhibitor with all of the associated warnings and drug and food interactions and is indicated only for idiopathic Parkinson’s disease.


Patient is being treated for Parkinson’s disease and is intolerant to selegiline.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top